 
- 积分
- 416
- 威望
- 416
- 包包
- 1859
|
HIGHLIGHTS OF PRESCRIBING
9 K( e9 ^1 t M' I+ Z( UINFORMATION + \0 L" n/ G# E3 b) c2 \
These highlights do not include all of the : e9 J9 K3 H' k; S% `% i
information needed to use PROVENGE®5 K% O; n6 B" W$ [ t$ S$ h+ z, E
6 ]+ l9 l# H; R% ], J+ d
(sipuleucel - T) safely and effectively. See f ull
$ }# H; Q+ T' |1 n! O3 O7 ?prescribing information for PROVENGE.
, r8 `$ F% P) e' O V9 i. mPROVENGE® (sipuleucel - T)
5 w, J# g) j4 R6 O. l# NSuspension for Intravenous Infusion $ x" D4 f+ n' S3 E
Initial U.S. Approval: 2010
) X9 b9 @! C! O: V& I- - - - - - - INDICATIONS AND USAGE - - - - - - |
-
总评分: 威望 + 2
包包 + 10
查看全部评分
|